Sphere Fluidics’ Expansion and Vision

In this interview, Rob Trainor, the Vice President of Operations at Sphere Fluidics, sits down for an insightful conversation detailing the completion of Sphere Fluidics’ new state-of-the-art facilities and the strategic decisions behind their office move and rebranding.

Toll Like Receptor 8 drugs in development by Therapy Areas, Indications, Stages, MoA, RoA, Molecule Type, and Key Players, 2023

Share this article The report also covers products from therapy areas such as Oncology, Immunology, and Infectious Disease which include the indications Solid Tumor, Melanoma,

November 30, 2023

Ancillary Cannabis Stocks Hold Prices the Best

As we described in an article released earlier, the Global Cannabis Stock Index moved lower in November, falling 9.5%. It is now down 8.3% in 2024. In this

November 30, 2024

FDA Outlines Rules for Telling Clinicians About Unapproved Uses of Drugs, Devices

The FDA has released revised draft guidance on communicating with healthcare professionals (HCPs) about unapproved uses of approved drugs and devices. Once it’s finalized, the

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.